Patents Assigned to Bartos Patent Development & Holding Company, Limited
  • Method of determining the diagnostic value of monitoring serum-CEA-levels in a carcinoma patient undergoing therapy
    Patent number: 4863853
    Abstract: The diagnostic value of monitoring serum-CEA-levels in a patient undergoing therapy for a cancerous tumor is determined by obtaining cytosole from the tumor and quantitatively determining its CEA content. Preferably, the cytosole used is obtained from a portion of the tumor used for hormone receptor analysis.
    Type: Grant
    Filed: April 14, 1983
    Date of Patent: September 5, 1989
    Assignee: Bartos Patent Development and Holding Company Limited
    Inventors: Dezso S. Bartos, Denis Fitzpatrick
  • Serioimmunological process for determining the in-vivo effectiveness of cytostatic agents
    Patent number: 4686194
    Abstract: The in-vivo effectiveness of cytostatic agents against immunological active tumors is determined by measuring immune markers and/or immune parameters in the serum before and up to 3 days after the application of the cytostatic agent. Preferably the deviation of coomplement binding capacity is used as immune parameter.
    Type: Grant
    Filed: April 14, 1983
    Date of Patent: August 11, 1987
    Assignee: Bartos Patent Development & Holding Company, Limited
    Inventors: Dezso S. Bartos, Denis Fitzpatrick